| Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. | |
| | |
MedLine Citation:
|
PMID: 20861123 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Hemoglobin A1c (A1c) was recently added to the diagnostic criteria for diabetes and prediabetes. OBJECTIVE: Our objective was to examine performance of A1c in comparison with fasting plasma glucose (FPG) in diagnosing dysglycemia in older adults. DESIGN AND SETTING: We conducted a cross-sectional analysis of data from the Health, Aging, and Body Composition study at yr 4 (2000-2001) when FPG and standardized A1c measurements were available. PARTICIPANTS: Of 3075 persons (aged 70-79 yr, 48% men, 42% Black) at study entry, 1865 participants without known diabetes who had appropriate measures were included. MAIN OUTCOME MEASURES: Sensitivity and specificity of A1c-based diagnoses were compared with those based on FPG and the proportion of participants identified with dysglycemia by each measure. RESULTS: Of all participants, 2.7 and 3.1% had undiagnosed diabetes by FPG≥126 mg/dl and A1c≥6.5%, respectively. Among the remaining participants, 21.1% had prediabetes by impaired fasting glucose (≥100 mg/dl) and 22.2% by A1c≥5.7%. Roughly one third of individuals with diabetes and prediabetes were identified by either FPG or A1c alone and by both tests simultaneously. Sensitivities and specificities of A1c compared with FPG were 56.9 and 98.4% for diabetes and 47.0 and 84.5% for prediabetes, respectively. Blacks and women were more likely to be identified with dysglycemia by A1c than FPG. CONCLUSIONS: In this older population, we found considerable discordance between FPG- and A1c-based diagnosis of diabetes and prediabetes, with differences accentuated by race and gender. Broad implementation of A1c to diagnose dysglycemic states may substantially alter the epidemiology of these conditions in older Americans. |
| | |
Authors:
|
Kasia J Lipska; Nathalie De Rekeneire; Peter H Van Ness; Karen C Johnson; Alka Kanaya; Annemarie Koster; Elsa S Strotmeyer; Bret H Goodpaster; Tamara Harris; Thomas M Gill; Silvio E Inzucchi |
Related Documents
:
|
19794923 - Improvement of glucose metabolism in patients with impaired glucose tolerance or diabet... 8325993 - Lack of control by glucose of ultradian insulin secretory oscillations in impaired gluc... 21035763 - High-fat-diet-induced obesity and heart dysfunction are regulated by the tor pathway in... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't Date: 2010-09-22 |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 95 ISSN: 1945-7197 ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-06 Completed Date: 2011-01-14 Revised Date: 2011-12-21 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 5289-95 Citation Subset: AIM; IM |
Affiliation:
|
Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, P.O. Box 208088, 333 Cedar Street, SHM IE-61, New Haven, Connecticut 06520-8088, USA. kasia.lipska@yale.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Blood Glucose / analysis Continental Population Groups Cross-Sectional Studies Diabetes Mellitus / blood, diagnosis* Diabetes Mellitus, Type 2 / blood, diagnosis Fasting Female Hemoglobin A, Glycosylated / diagnostic use* Humans Male Prediabetic State / blood, diagnosis* Sex Characteristics |
| Grant Support | |
ID/Acronym/Agency:
|
2P30AG021342/AG/NIA NIH HHS; K24 AG021507-09/AG/NIA NIH HHS; K24 AG021507-10/AG/NIA NIH HHS; K24AG021507/AG/NIA NIH HHS; N01-AG-6-2101/AG/NIA NIH HHS; N01-AG-6-2103/AG/NIA NIH HHS; N01-AG-6-2106/AG/NIA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Hemoglobin A, Glycosylated |
| Comments/Corrections | |
Comment In:
|
J Clin Endocrinol Metab. 2010 Dec;95(12):5203-6
[PMID:
21131541
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67.
Next Document: Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation.